Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.10.3.2 (
laccase
)
4,656
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ligninolytic enzymes, including
laccase
(
Lac
), manganese peroxidase (MnP) and lignin peroxidase (LiP), have attracted much attention in the degradation of contaminants. Genes of
Lac
(1827 bp), MnP (1134 bp) and LiP (1119 bp) were cloned from
Aspergillus
sp. TS-A, and the recombinant
Lac
(69 kDa), MnP (45 kDa) and LiP (
35 kDa
) were secretory expressed in
Pichia pastoris
GS115, with enzyme activities of 34, 135.12 and 103.13 U l
-1
, respectively. Dyes of different structures were treated via the recombinant ligninolytic enzymes under the optimal degradation conditions, and the result showed that the decolourization rate of
Lac
on Congo red (CR) in 5 s was 45.5%. Fourier-transform infrared spectroscopy, gas chromatography-mass spectrometry analysis and toxicity tests further proved that the ligninolytic enzymes could destroy the dyes, both those with one or more azo bonds, and the degradation products were non-toxic. Moreover, the combined ligninolytic enzymes could degrade CR more completely compared with the individual enzyme. Remarkably, besides azo dyes, ligninolytic enzymes could also degrade triphenylmethane and anthracene dyes. This suggests that ligninolytic enzymes from
Aspergillus
sp. TS-A have the potential for application in the treatment of contaminants.
...
PMID:Degradation and detoxification of azo dyes with recombinant ligninolytic enzymes from
Aspergillus
sp. with secretory overexpression in
Pichia pastoris
. 3304 30